Literature DB >> 15694671

A wide role for NOTCH1 signaling in acute leukemia.

Raffaella Chiaramonte1, Andrea Basile, Elena Tassi, Elisabetta Calzavara, Valentina Cecchinato, Vincenzo Rossi, Andrea Biondi, Paola Comi.   

Abstract

NOTCH1 is involved in the pathogenesis of T-acute lymphoblastic leukemia (T-ALL) carrying the very rare translocation t(7;9)(q34;q34.3). We analyzed the expression of genes belonging to NOTCH pathway, in acute leukemia primary samples and lymphoblastoid cell lines. NOTCH1 pathway activation represents a common feature of T-ALL when compared to acute myelogenous leukemia (AML) and B-cell precursor acute lymphoblastic leukemia. The contemporary expression of NOTCH1 and its ligands on cell surface contributes to high levels of pathway activity. AML primary samples show high levels of JAGGED1 expression despite the low NOTCH1 pathway activation, consistent with an autonomous JAGGED1 signaling in myeloid leukemogenesis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15694671     DOI: 10.1016/j.canlet.2004.07.022

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  25 in total

1.  Activation of Notch signal pathway is associated with a poorer prognosis in acute myeloid leukemia.

Authors:  Xin Xu; Yu Zhao; Maozhong Xu; Qiuxin Dai; Wenjun Meng; Jiangang Yang; Rujuan Qin
Journal:  Med Oncol       Date:  2010-09-02       Impact factor: 3.064

Review 2.  Ikaros and tumor suppression in acute lymphoblastic leukemia.

Authors:  Kimberly J Payne; Sinisa Dovat
Journal:  Crit Rev Oncog       Date:  2011

3.  Evidence for functional redundancy between C. elegans ADAM proteins SUP-17/Kuzbanian and ADM-4/TACE.

Authors:  Sophie Jarriault; Iva Greenwald
Journal:  Dev Biol       Date:  2005-09-27       Impact factor: 3.582

4.  Notch activation is an early and critical event during T-Cell leukemogenesis in Ikaros-deficient mice.

Authors:  Alexis Dumortier; Robin Jeannet; Peggy Kirstetter; Eva Kleinmann; MacLean Sellars; Nuno R dos Santos; Christelle Thibault; Jochen Barths; Jacques Ghysdael; Jennifer A Punt; Philippe Kastner; Susan Chan
Journal:  Mol Cell Biol       Date:  2006-01       Impact factor: 4.272

5.  Notch signaling maintains proliferation and survival of the HL60 human promyelocytic leukemia cell line and promotes the phosphorylation of the Rb protein.

Authors:  Guo-Hui Li; Yu-Zhen Fan; Xiao-Wei Liu; Bing-Fang Zhang; Dan-Dan Yin; Fei He; Si-Yong Huang; Zhi-Jie Kang; Heng Xu; Qiang Liu; Yan-Lan Wu; Xiao-Li Niu; Li Zhang; Li Liu; Miao-Wang Hao; Hua Han; Ying-Min Liang
Journal:  Mol Cell Biochem       Date:  2010-02-16       Impact factor: 3.396

6.  Notch1 promotes survival of E2A-deficient T cell lymphomas through pre-T cell receptor-dependent and -independent mechanisms.

Authors:  Erica J Reschly; Christina Spaulding; Tomas Vilimas; W Vallen Graham; Rachel L Brumbaugh; Iannis Aifantis; Warren S Pear; Barbara L Kee
Journal:  Blood       Date:  2006-01-31       Impact factor: 22.113

7.  Notch is a critical regulator in cervical cancer by regulating Numb splicing.

Authors:  Cai Rong; Yu Feng; Zhou Ye
Journal:  Oncol Lett       Date:  2017-02-07       Impact factor: 2.967

Review 8.  Mechanisms and clinical prospects of Notch inhibitors in the therapy of hematological malignancies.

Authors:  Yulia Nefedova; Dmitry Gabrilovich
Journal:  Drug Resist Updat       Date:  2008-10-31       Impact factor: 18.500

9.  The oncogenic roles of Notch1 in astrocytic gliomas in vitro and in vivo.

Authors:  Peng Xu; Mingzhe Qiu; Zhiyong Zhang; Chunsheng Kang; Rongcai Jiang; Zhifan Jia; Guangxiu Wang; Hao Jiang; Peiyu Pu
Journal:  J Neurooncol       Date:  2009-09-22       Impact factor: 4.130

Review 10.  Notch signaling in pediatric malignancies.

Authors:  Patrick A Zweidler-McKay
Journal:  Curr Oncol Rep       Date:  2008-11       Impact factor: 5.075

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.